ResMed Earnings
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$2.70
ResMed earnings summary
ResMed is scheduled to report Sep/2026 earnings on Oct 29, 2026 after the market closes, with analysts expecting EPS of $2.70. In its most recent report on Aug 13, 2026 (Q4 2026), RMD posted EPS of $2.64. Revenue for the quarter was $1.46 billion.
Quarterly EPS is up 2.3% from the same quarter a year earlier. Across the last 16 reports, RMD shares moved an average of 3.3% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
RMD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $2.64 | — | +3.1% |
| May 1, 2026 | — | $2.74 | — | +0.8% |
| Jan 30, 2026 | — | $2.68 | — | +5.2% |
| Oct 31, 2025 | — | $2.37 | — | +1.9% |
| Aug 8, 2025 | — | $2.58 | — | +0.3% |
| Apr 24, 2025 | — | $2.48 | — | +1.7% |
| Jan 31, 2025 | — | $2.34 | — | +0.3% |
| Oct 25, 2024 | — | $2.11 | — | -4.6% |
| Aug 9, 2024 | — | $1.97 | — | +5.2% |
| Apr 26, 2024 | — | $2.04 | — | -0.5% |
| Jan 25, 2024 | — | $1.42 | — | +0.9% |
| Oct 27, 2023 | — | $1.49 | — | +13.5% |
| Aug 11, 2023 | — | $1.55 | — | -7.7% |
| Apr 28, 2023 | — | $1.58 | — | -3.9% |
| Jan 27, 2023 | — | $1.53 | — | +0.0% |
| Oct 28, 2022 | — | $1.43 | — | -3.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.